{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-267472","form_type":"8-K","ticker":"ALXO","cik":"0001810182","company_name":"ALX ONCOLOGY HOLDINGS INC","filed_at":"2026-06-11T20:02:14+00:00","discovered_at":"2026-06-11T20:03:00.673620+00:00","generated_at":"2026-06-11T20:03:09.750853+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.12,"calibrated_materiality_score":0.12,"confidence":"high","headline":"ALX Oncology shareholders elect directors, approve executive compensation and auditor at annual meeting","bullets":["Vote results: Daniel Curran (100.9M for), Rekha Hemrajani (82.7M for), Chris Takimoto (100.9M for) elected to Class II board.","Say-on-pay advisory vote passed: 84.5M for, 13.5M against, 2.9M abstain.","KPMG LLP ratified as independent auditor for FY2026: 119.3M for, 1.8K against, 9.3K abstain.","All director nominees elected; significant withheld votes for Hemrajani (18.3M) but still elected."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-267472","json":"https://secwatch.observer/filing/0001193125-26-267472.json","markdown":"https://secwatch.observer/filing/0001193125-26-267472.md","text":"https://secwatch.observer/filing/0001193125-26-267472.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526267472/0001193125-26-267472-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526267472/alxo-20260610.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T20:03:09.750853+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1ff801fbcd87798cb4e727b7419937daf469ba93","claim":"ALX ONCOLOGY HOLDINGS INC shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.","evidence_excerpt":"Proposal 3: Ratification of the Appointment of Independent Registered Public Accounting Firm For Against Abstain 119,293,775 1,797 9,292","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526267472/0001193125-26-267472-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-10"}],"fact_type":"shareholder_vote"},{"claim_id":"a22e1f3d1852ea7b17c92f5bf0cf7f8a73423f74","claim":"ALX ONCOLOGY HOLDINGS INC shareholders approved Advisory Vote on the Compensation of the Company's Named Executive Officers at the 2026-06-10 meeting.","evidence_excerpt":"Proposal 2: Advisory Vote on the Compensation of the Company’s Named Executive Officers For Against Abstain Broker Non-Votes 84,540,061 13,497,711 2,953,259 18,313,833","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526267472/0001193125-26-267472-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-10"}],"fact_type":"shareholder_vote"},{"claim_id":"ab563d328931f0d8287b365cdab13ff2f3ee1583","claim":"ALX ONCOLOGY HOLDINGS INC shareholders approved Election of Two Class II Directors at the 2026-06-10 meeting.","evidence_excerpt":"Proposal 1: Election of Two Class II Directors Name of Director For Withheld Broker Non-Votes Daniel Curran, M.D. 100,933,233 57,798 18,313,833 Rekha Hemrajani 82,732,430 18,258,601 18,313,833 Chris Takimoto, M.D., Ph.D., F.A.C.P. 100,946,696 44,335 18,313,833","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526267472/0001193125-26-267472-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-10"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}